摘要
背景:轻度认知障碍(MCI)患者被认为是发展为痴呆的高危人群,因此有可能成为预防干预的目标。到目前为止,还没有药物干预措施被证明是有效的。最新的证据为舞蹈通过提高神经可塑性而对认知产生有益影响的假说奠定了基础。目的:探讨结构化的模块化舞蹈病干预(INDAK)是否能提高菲律宾老年人MCI的认知水平。方法:在菲律宾马里基纳市的社区人群中进行了一项双武器、单盲、准实验研究.年龄在60岁以上的MCI患者207人,通过自我分配的方式参加舞蹈(N=101)和对照组(N=106)。干预组接受INDAK,包括8种类型的舞厅舞,其复杂性增加,持续1小时,每周两次,持续48周。神经学家和心理学家对使用阿尔茨海默病评估量表(ADAS-Cog)、菲律宾版的蒙特利尔认知评估量表(MoCA-P)、波士顿命名测验(BNT)、老年抑郁量表(GDS)、日常生活工具活动能力(IADL)和痴呆残疾评估(DAD)进行的基线和干预后评估的群体分配法视而不见。结果:基线社会人口学和临床特征在各组间没有差异。比较舞蹈者和对照组基线和48周评估的平均差异,表明干预组在ADAS-Cog、MoCA-P、BNT和GDS方面有所改善。结论:INDAK是一种新的、生态的、廉价的非药物干预措施,可提高菲律宾老年MCI患者的认知能力。
关键词: 轻度认知障碍,认知,非药物干预,舞蹈,社区为基础,结构化和模块化。
Current Alzheimer Research
Title:Improving Cognition through Dance in Older Filipinos with Mild Cognitive Impairment
Volume: 15 Issue: 12
关键词: 轻度认知障碍,认知,非药物干预,舞蹈,社区为基础,结构化和模块化。
摘要: Background: People with mild cognitive impairment (MCI) are considered a high-risk population for developing dementia and therefore potential targets for preventive interventions. So far, no pharmacological interventions have proven to be effective. Latest evidence has laid the groundwork for the hypothesis that dancing can have beneficial effect on cognition by improving neuroplasticity.
Objective: This study aimed to examine whether a structured modular ballroom dance intervention (INDAK) could improve cognition among Filipino older persons with MCI.
Methods: A two-armed, single-blinded, quasi-experimental study was conducted in a community-based population at Marikina City, Philippines. Two hundred and seven participants older than 60 years old with MCI participated through self-assigned allocation to dance (N=101) and control (N=106) groups. The intervention group received INDAK consisting eight types of ballroom dances with increasing complexity lasting one hour, twice a week for 48 weeks. Neurologists and psychologists blinded to the group allocation administered baseline and post intervention assessments using Alzheimer’s Disease Assessment Scale – Cognitive (ADAS-Cog), Filipino version of the Montreal Cognitive Assessment (MoCA-P), Boston Naming Test (BNT), Geriatric Depression Scale (GDS), Instrumental Activities of Daily Living (IADL) and Disability Assessment for Dementia (DAD).
Results: Baseline sociodemographic and clinical characteristics did not differ between groups. The mean differences between baseline and 48-week assessments were compared between dancers and controls, showing that the intervention group improved in ADAS-Cog, MoCA-P, BNT and GDS.
Conclusion: INDAK is potentially a novel, ecological and inexpensive non-pharmacological intervention that can improve cognition among older Filipinos with MCI.
Export Options
About this article
Cite this article as:
Improving Cognition through Dance in Older Filipinos with Mild Cognitive Impairment, Current Alzheimer Research 2018; 15 (12) . https://dx.doi.org/10.2174/1567205015666180801112428
DOI https://dx.doi.org/10.2174/1567205015666180801112428 |
Print ISSN 1567-2050 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5828 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Flavonoids in the Treatment of Alzheimer’s and Other Neurodegenerative Diseases
Current Medicinal Chemistry Kidney Dysfunction is Associated with a High Burden of Cerebral Small Vessel Disease in Primary Intracerebral Hemorrhage
Current Neurovascular Research Inflammation as a Therapeutic Target in Acute Ischemic Stroke Treatment
Current Topics in Medicinal Chemistry Therapy of XDR TB with Thioridazine a Drug Beyond Patent Protection but Eligible for Patent “As New Use”
Recent Patents on Anti-Infective Drug Discovery Vertical and Horizontal Convergences of Targeting Pathways in Combination Therapy with Baicalin and Jasminoidin for Cerebral Ischemia
CNS & Neurological Disorders - Drug Targets Anti-Vascular Endothelial Growth Factor Drug Treatment of Diabetic Macular Edema: The Evolution Continues
Current Diabetes Reviews Recent Updates on Current and Upcoming Biomarkers for Cardiovascular Diseases
Current Pharmaceutical Design Unraveling the Action Mechanism of Buyang Huanwu Tang (BYHWT) for Cerebral Ischemia by Systematic Pharmacological Methodology
Combinatorial Chemistry & High Throughput Screening Phytoestrogens in Postmenopause: The State of the Art from a Chemical, Pharmacological and Regulatory Perspective
Current Medicinal Chemistry Acetylcholinesterase: Molecular Modeling with the Whole Toolkit
Current Topics in Medicinal Chemistry Strategies for Continued Successful Treatment in Patients with Alzheimer’s Disease: An Overview of Switching Between Pharmacological Agents
Current Alzheimer Research Depressed or Demented: Common CNS Drug Targets? !
Current Drug Targets - CNS & Neurological Disorders A Comprehensive Review of the Genus Pyrola Herbs in Traditional Uses, Phytochemistry and Pharmacological Activities
Current Topics in Medicinal Chemistry Editorial: Pain in Dementia: A Distressing Combination of Several Factors
Current Alzheimer Research Oxidative Stress and Pathophysiology of Ischemic Stroke: Novel Therapeutic Opportunities
CNS & Neurological Disorders - Drug Targets Chemical and Potential Biological Perspectives of Genus Sarcococca (Buxaceae)
The Natural Products Journal Glycyrrhizic Acid Ameliorates Cognitive Impairment in a Rat Model of Vascular Dementia Associated with Oxidative Damage and Inhibition of Voltage-Gated Sodium Channels
CNS & Neurological Disorders - Drug Targets Formaldehyde as a trigger for protein aggregation and potential target for mitigation of age-related, progressive cognitive impairment
Current Topics in Medicinal Chemistry Glutamate Receptors in Human Caudate Nucleus in Normal Aging and Alzheimer’s Disease
Current Alzheimer Research Pharmacogenetics of Angiotensin-Converting Enzyme Inhibitors in Patients with Alzheimer's Disease Dementia
Current Alzheimer Research